The establishment of Asia-Pacific Leukemia Consortium (APLC) on the 8th of Sept 2021 serves as a platform to facilitate greater collaboration across the Asia-Pacific region for different stakeholders:
Clinicians
Researchers
Healthcare professionals
Industry partners
To improve the management of Leukemia and related diseases in Asia-Pacific through the collective collaboration of valued partners and a targeted approach to bench-to-bedside research, translation of real-world evidence and bio-resources.
Establishing value partnerships within the ecosystem of clinicians, researchers, healthcare providers and Bio-pharmaceutical industry to maximize resources and accelerate improve in patient care.
Clinical trials
Real-world Disease Registry and Genetic & Tissue Repository
Education
Patient advocacy
Myeloid Working Group
Lymphoid Working Group
Real-World Disease Registry Working Group
Current members' countries/regions include Australia, China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, Thailand.
Main Office
Asia-Pacific Leukemia Consortium (APLC) c/o Singapore General Hospital Pte Ltd
10 Hospital Boulevard #19-01 Singapore 168582
Email:
[email protected]
Website:
